IL1B and ovarian carcinoma: The effect of intraperitoneal (i.p.)injection of recombinant human interleukin-1 beta (rhIL-1 beta) was studied in three i.p. nude mouse xenograft models of human ovarian cancer (HU, OS, and LA).